C4 glomerulopathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Norina Usman (talk | contribs) |
Norina Usman (talk | contribs) |
||
Line 8: | Line 8: | ||
===Prevalence=== | ===Prevalence=== | ||
There is not much information available about the prevalence of the disease. | |||
===Incidence=== | ===Incidence=== | ||
===Age=== | ===Age=== |
Revision as of 00:13, 3 August 2020
C4 glomerulopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
C4 glomerulopathy epidemiology and demographics On the Web |
American Roentgen Ray Society Images of C4 glomerulopathy epidemiology and demographics |
Risk calculators and risk factors for C4 glomerulopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]
Overview
Epidemiology and Demographics
Prevalence
There is not much information available about the prevalence of the disease.
Incidence
Age
Patients of all age groups may develop C4 glomerulopathy.
Gender
Race
There is no racial predilection to C4 glomerulopathy.
Geographic Distribution
C4 glomerulopathy can affect both developed or underdeveloped countries equally.